GIIS069-Grupo de Investigación Clínica en Enfermedades Infecciosas

Avendano-Sola C, Ramos-Martinez A, Munez-Rubio E, Ruiz-Antoran B, Malo de Molina R, Torres F, Fernandez-Cruz A, Calderon-Parra J, Payares-Herrera C, Diaz de Santiago A, Romera-Martinez I, Pintos I, Lora-Tamayo J, Mancheno-Losa M, Paciello M, Martinez-Gonzalez A, Vidan-Estevez J, Nunez-Orantos M, Isabel Saez-Serrano M, Porras-Leal M, Jarilla-Fernandez M, Villares P, Perez de Oteyza J, Ramos-Garrido A, Blanco L, Madrigal-Sanchez M, Rubio-Batlles M, Velasco-Iglesias A, Paño Pardo J, Moreno Chulilla J, Muniz-Diaz E, Casas-Flecha I, Perez-Olmeda M, Garcia-Perez J, Alcami J, Bueno J, Duarte R, ConPlas-19 Study Grp . A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia JOURNAL OF CLINICAL INVESTIGATION. 10.1172/JCI152740. Q-1. F.I-13,6

Uranga Murillo I, Morte Romea E, Hidalgo Arizón S, Pesini Martín C, García-Mulero S, Sierra J, Santiago García L, Arias Cabrero M, de Miguel Samaniego D, Encabo Berzosa M, Gracia Tello B, Sanz-Pamplona R, Martínez Lostao L, Galvez E, Paño Pardo J, Ramírez Labrada A, Pardo Jimeno J. Integrated analysis of circulating immune cellular and soluble mediators reveals  specific COVID19 signatures at hospital admission with utility for prediction of  clinical outcomes. Theranostics. 10.7150/thno.63463. Q-1. F.I-13,3

Garzon-Tituana M, Sierra Monzón J, Comas Calmet L, Santiago García L, Khaliulina T, Uranga Murillo I, Ramírez Labrada A, Tapia E, Morte Romea E, Algarate Cajo S, Couty L, Camerer E, Bird P, Seral García C, Luque Gómez P, Paño Pardo J, Gálvez Buerba E, Pardo Jimeno J, Arias Cabrero M. Granzyme A inhibition reduces inflammation and increases survival during abdominal sepsis Theranostics. 10.7150/thno.49288. Q-1. F.I-13,3

Peñalva G, Cantón R, Pérez-Rodríguez M, González-López J, Rodríguez-Baño J, Barrio-Tofiño E, Kirkegaard-Biosca C, Sánchez-Romero I, Gutiérrez-Villanueva A, Marrodán-Ciordia T, Guerra-Laso J, Rosario-Quintana C, Suárez-Hormiga L, Cámara J, Puig-Asensio M, Heredero E, Sepúlveda M, Rodríguez-Díaz J, Merino E, Cercenado E, Villa S, Siller M, Arnaiz F, Seral García C, Lepe J, Cisneros J, Paño Pardo J, BMR_SEIMC Study Group . Burden of bacterial antimicrobial resistance among hospitalised patients in Spain: findings from three nationwide prospective studies. Lancet Regional Health-Europe. 10.1016/j.lanepe.2025.101220. Q-1. F.I-13

Girón-Ortega J, Fernández-Guerrero R, de Oca Arjona M, Galán-Sanchez F, Pellejero Sagastizábal G, Morte Romea E, de Cueto M, Garcia M, Palacios-Baena Z, Jorge S, Rodríguez-Baño J, Retamar-Gentil P, NO-BACT Team . Antibiotic use and outcome in patients with negative blood cultures, a new target population for antimicrobial stewardship interventions: A prospective multicentre cohort (NO-BACT). JOURNAL OF INFECTION. 10.1016/j.jinf.2023.11.013. Q-1. F.I-11,9

Seco M, Paño Pardo J, Schoergenhofer C, Dings C, Lehr T, Herth F, Krendyukov A, Straub C, Kappler M, Jilma B, Fricke H, Pardo Jimeno J, de Miguel Samaniego D, Thiemann M, Bergmann M, Walczak H, Hoeger T. Efficacy and safety of asunercept, a CD95L-selective inhibitor, in hospitalised patients with moderate-to-severe COVID-19: ASUNCTIS, a multicentre, randomised, open-label, controlled, phase 2 trial EClinicalMedicine. 10.1016/j.eclinm.2024.102879. Q-1. F.I-10

González Pastor R, Hernandez Y, Gimeno Gracia M, de Martino Rodríguez A, Man Y, Hallden G, Quintanilla M, de la Fuente J, Martín Duque M. Coating an adenovirus with functionalized gold nanoparticles favors uptake, intracellular trafficking and anti-cancer therapeutic efficacy Acta Biomaterialia. 10.1016/j.actbio.2021.07.047. Q-1. F.I-9,6

Barac A, Gupta N, Jokelainen P, Tsiodras S, Mora-Rillo M, Gkrania-Klotsas E, Paño Pardo J, Bulescu C, Pellejero Sagastizábal G, Goorhuis A, Mendoza M, Van der Ende J, Lescure F, Grobusch M, Drexler J. Yellow fever in South America in 2025: a concerning increase, but a true resurgence? CLINICAL MICROBIOLOGY AND INFECTION. 10.1016/j.cmi.2025.06.036. Q-1. F.I-8,5

Bartoletti M, Azap O, Barac A, Ben Selma M, Ergonul O, Gkrania-Klotsas E, Grossi P, Krause R, Nagavci B, Paño Pardo J, Pierrotti L, Power N, Rodriguez-Bano J, Sibani M, Slavin M, Szabo B, Tazza B, Tsang N, Tsiodras S, Zollner-Schwetz I, Chemaly R, ESCMID Study Grp Infections Compromised Hosts , ESCMID Study Grp Resp Viruses . Management of COVID-19 in immunocompromised patients: an European Society of Clinical Microbiology and Infectious Diseases consensus document CLINICAL MICROBIOLOGY AND INFECTION. 10.1016/j.cmi.2025.05.032. Q-1. F.I-8,5

Scudeller L, Paño Pardo J, ESCMID Guidelines Subcomm , ESCMID Executive Comm . The European Society of Clinical Microbiology and Infectious Diseases 2025-2029 pipeline of clinical practice guidelines: planning ahead for a greater impact CLINICAL MICROBIOLOGY AND INFECTION. 10.1016/j.cmi.2025.03.005. Q-1. F.I-8,5